Intrinsic Value

NeuroSense Therapeutics Ltd. (NRSN)


+0.05 (+2.99%)

Enterprise Value -
Net Debt -11.06
Equity Value -
Shares Outstanding 6.24
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt